Oocyte Retrieval and Virtual Reality (REVPO)
REVPO
Study of Analgesic Effect of Virtual Reality During Oocyte Retrieval in in Vitro Fecondation Protocols: Controlled Randomized Trial
2 other identifiers
interventional
150
1 country
1
Brief Summary
The aim of the study is to ass wether or not the use of virtual reality during oocyte retrieval provides a better pain relief for patients, compared to a standard analgesic procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 25, 2021
CompletedStudy Start
First participant enrolled
June 9, 2021
CompletedFirst Posted
Study publicly available on registry
June 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedSeptember 19, 2024
September 1, 2024
2.7 years
May 25, 2021
September 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain during oocyte retrieval, assessed by NRS
Oral evaluation of pain during the intervention for oocyte retrieval, evaluated by a Numeric Rating Scale (NRS) : from 0 (meaning no pain at all) to 10 (meaning worse pain possible).
day 0 (During the intervention for oocyte retrieval)
Secondary Outcomes (5)
Pain after oocyte retrieval, assessed by NRS
hour 1 (In the hour following the oocyte retrival)
Painkillers consumption during the 48 hours following the oocyte retrieval.
Day 5
Patient satisfaction concerning the use of virtual reality during the oocyte retrieval
hour 1 (In the hour following the oocyte retrival)
Gynaecologist satisfaction concerning the use of virtual reality during the oocyte retrieval
hour 1 (In the hour following the oocyte retrival)
Efficacy of the use of virtual reality during oocyte retrieval
hour 1 (In the hour following the oocyte retrival)
Study Arms (2)
Virtual Reality Group
EXPERIMENTALin this group, patients will use virtual reality during the oocyte retrieval plus the standard anesthesic procedure (local anesthesia)
Standard Group
SHAM COMPARATORin this group, patients will receive the standard anesthesic procedure during the oocyte retrieval wich is local anesthesia
Interventions
A virtual reality device will be install on the patient 3-5 minutes before the beginning of the oocyte retrieval. The device will be wearing by the patient during the entire intervention and 2 minutes after the end of the ponction.
Eligibility Criteria
You may qualify if:
- Aged between 18 and 43 years
- First attempt of oocyte retrieval under local anesthesia in the context of a protocol for Medically Assisted Procreation
You may not qualify if:
- Former attempt of oocyte retrieval
- Poor oocyte stock : \> 40 years AND low markers (AMH \< 0.5-1.1 ng/ml OR AFC \< 5-7)
- Unsteady epilepsia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Clermont-Ferrand
Clermont-Ferrand, 63000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Camille Valdeyron
University Hospital, Clermont-Ferrand
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2021
First Posted
June 23, 2021
Study Start
June 9, 2021
Primary Completion
March 1, 2024
Study Completion
July 1, 2024
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share